You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cytogenetic abnormality

Showing 1 - 25 of 828
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Completed
  • Relapsed Acute Myeloid Leukemia
  • +3 more
  • VAH regimen
  • VEN+HMA regimen
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 8, 2022

Genomic Instability in Vascular Surgeons

Completed
  • Cytogenetic Abnormality
  • Radiation Exposure
  • Cytogenetic analysis
  • Valladolid, Castilla Y León, Spain
    Hospital Clínico Universtario de Valladolid
Apr 23, 2020

Based on Molecular Cytogenetic Aberration and Treatment Response

Unknown status
  • Risk-directed Therapy
  • +3 more
  • Justified risk stratification based on MRD after three course chemo therapy
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 31, 2019

Chronic Lymphocytic Leukemia (CLL) Trial

Completed
  • Chronic Lymphocytic Leukemia (CLL)
    • (no location specified)
    Apr 5, 2022

    MDS Trial in Germany, United States (lenalidomide)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Scottsdale, Arizona
    • +31 more
    Nov 6, 2019

    Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional

    Completed
    • Acute Myeloid Leukemia
    • Conventional Cytogenetics Studies
    • +2 more
    • Assiut, Egypt
      South Egypt Cancer Institute
    Mar 7, 2022

    MDS Trial in London (lenalidomide)

    Completed
    • Myelodysplastic Syndromes
    • London, United Kingdom
      King's College Hospital NHS Foundation Trust
    Feb 26, 2019

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Orca-Q
    • Gainesville, Florida
      University of Florida
    Aug 26, 2022

    Severe Aplastic Anemia Who Developed High Risk Clonal Evolution

    Completed
    • Severe Aplastic Anemia
      • Bethesda, Maryland
        National Heart, Lung and Blood Institute (NHLBI)
      Apr 7, 2022

      MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

      Recruiting
      • Myelodysplastic Syndromes
      • Myeloproliferative Chronic Myelomonocytic Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)

      Recruiting
      • Acute Myeloid Leukemia
      • mitoxantrone + etoposide + gemtuzumab ozogamicin
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Feb 9, 2022

      Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

      Withdrawn
      • Myelodysplastic Syndrome
      • SyB C-1101 and Azacytidine
      • Nagoya, Aichi, Japan
      • +3 more
      Nov 14, 2022

      Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

      Active, not recruiting
      Has Results
      • Leukemia, Myeloid, Acute
      • Myelodysplastic Syndromes
      • New Haven, Connecticut
      • +94 more
      Jun 9, 2022

      Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

      Completed
      • Leukemia
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Sep 30, 2022

      Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

      Not yet recruiting
      • Multiple Myeloma in Relapse
      • Multiple Myeloma, Refractory
      • (no location specified)
      Oct 30, 2023

      Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

      Recruiting
      • Secondary Myelodysplastic Syndrome
      • Therapy-Related Myelodysplastic Syndrome
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Dec 1, 2022

      Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia

      Not yet recruiting
      • Acute Myeloblastic Leukemia
        • (no location specified)
        Aug 10, 2022

        Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571

        Completed
        Has Results
        • Philadelphia Positive Chronic Myeloid Leukemia
        • +2 more
        • STI571 400 mg
        • STI571 600 mg
        • Boston, Massachusetts
        • +11 more
        Jul 1, 2021

        Non-Hodgkin Lymphoma (NHL), Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial in Worldwide (VOB560, MIK665)

        Recruiting
        • Non-Hodgkin Lymphoma (NHL)
        • +2 more
        • Gent, Belgium
        • +9 more
        Mar 18, 2022

        Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

        Active, not recruiting
        • Acute Leukemia
        • +3 more
        • cytogenetic analysis
        • La Jolla, California
        • +136 more
        Aug 16, 2021

        MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

        Completed
        Has Results
        • Myelodysplastic Syndromes
        • Saint Louis, Missouri
        • +20 more
        Dec 28, 2022

        Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United

        Completed
        Has Results
        • Adult Acute Basophilic Leukemia
        • +16 more
        • Little Rock, Arkansas
        • +53 more
        Jan 13, 2022

        Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

        Active, not recruiting
        Has Results
        • Anemia
        • +3 more
        • Epoetin Alfa
        • +2 more
        • Birmingham, Alabama
        • +512 more
        Mar 1, 2022

        Analyze Occurrence of Transformation From Myelodysplastic

        Completed
        • Myelodysplastic Syndromes
        • Leukemia, Myeloid, Acute
          • Kobe, Hyogo, Japan
            Shinko Hospital
          Jun 13, 2022